Over 20 Total Lots Up For Auction at One Location - TX Cleansweep 06/25

GE Healthcare and Accuray collaborate to expand access, advance the practice of precision radiation therapy

Press releases may be edited for formatting or style | October 24, 2022 Rad Oncology
CHICAGO and SUNNYVALE, Calif., Oct. 21, 2022 /PRNewswire/ -- GE Healthcare and Accuray Incorporated (NASDAQ: ARAY) announced today that they have signed a global commercial collaboration agreement designed to provide solutions that make it possible for more healthcare teams around the world to tailor patients' care at every stage of their treatment journey. The two companies will make available a comprehensive offering that brings together GE Healthcare's precision diagnostic tools and Accuray Incorporated's innovative radiation therapy delivery capabilities to advance the practice of radiation therapy and help deliver personalized care to patients diagnosed with cancer.

The practice of radiation therapy requires high quality imaging to determine the size, shape and characteristics of tumors, and sophisticated delivery technology to help precisely target tumors, while differentiating and minimizing dose to healthy tissue. As advanced imaging continues to enable earlier diagnosis and identification of smaller lesions - the need for precision and accuracy of treatment will be of equal importance to enable clinicians to diagnose and treat earlier stage cancers with confidence. By bringing together GE Healthcare's imaging solutions and Accuray radiation therapy technologies, the collaboration seeks to improve diagnosis and treatment across the spectrum of cancer care. The collaboration will initially focus on addressing challenges in the treatment of lung and brain cancers – with an emphasis on early detection; functional diagnostics to better inform planning decisions; and targeted, precise treatment delivery. Additionally, GE Healthcare and Accuray Incorporated will seek to drive digitalization and interoperability as healthcare systems look to build cancer care pathway solutions and streamline workflows in radiation oncology.

"Personalized medicine demands precision in both diagnosis and delivery," said Jan Makela, President & CEO of Imaging for GE Healthcare. "As we continue to build out our oncology offerings to help enable more precise, connected and compassionate care, we are committed to helping cancer care providers gain the upper hand through our suite of diagnostic technologies that help improve detection, as well as clinical and operational efficiency. In the face of complex diagnoses, we work to make the first image count in order to help shorten the window from diagnosis to treatment. We're excited about the opportunity to work with Accuray and expand access to our advanced imaging tools as we aim to provide a pathway to earlier diagnosis and better treatment options."

You Must Be Logged In To Post A Comment